Key opinion leader (KOL): how to find the people your field actually listens to
A key opinion leader (KOL) is someone whose view moves a field. How to find KOLs in public records, what to ask them and the payment rules to check first.
A key opinion leader (KOL) is a person whose view on a specific subject changes what others in that field think and do. In medicine, that is the physician whose papers shift how colleagues treat a condition, or the surgeon other surgeons call before trying a new device. Drug and device companies use the term most, asking KOLs to advise on research, help design studies and explain new evidence to other clinicians. Startups and B2B marketers use it more loosely, for the people a market tends to follow.
For research, use a narrow definition: a KOL is someone whose judgment on your question carries weight with the people you need to persuade. Influence is narrow. In Paul Lazarsfeld and Elihu Katz's two-step flow theory, opinion leaders interpret information for others, and opinion leadership is usually treated as specific to one field, so a leader in one area can be a follower in another (Wikipedia: Opinion leadership). The cardiologist everyone quotes on heart failure may have little to say about wound care.
A KOL is an expert people listen to
A subject matter expert knows a topic well. A KOL knows it and is also listened to. You usually need both, and they are often different people. The nurse who changes wound dressings every day may know more about what fails at the bedside than the professor who wrote the guideline. The professor knows which evidence persuades other clinicians. Ask each about the part they know.
Start with your questions, then pick the groups
Here is a made-up example. A five-person startup has built a sensor that sits inside a wound dressing and flags early signs of infection in diabetic foot ulcers. Before designing a pilot study, the team wants to learn:
- How clinicians decide today when a wound needs more aggressive treatment.
- What a study would have to measure to persuade other specialists.
- What a hospital needs before it will buy and use a new device.
Each question points to a different group:
- Practitioners (question 1): wound-care nurses and clinic managers who see these patients daily.
- Academic KOLs (question 2): physicians and podiatrists who publish on diabetic foot ulcers, run trials or sit on guideline committees.
- Buyers and reviewers (question 3): hospital supply chain, value analysis and IT staff. How to interview B2B users, buyers and champions covers this group.
Find key opinion leaders in public records
Anyone can call themselves a thought leader. Public records are harder to fake.
- Publications. PubMed is free and contains more than 40 million citations and abstracts of biomedical literature. Search your condition and note who keeps appearing as an author on recent studies, reviews and guidelines.
- Clinical trials. Each ClinicalTrials.gov record shows what is being studied, where the study is being conducted and who to contact, as supplied by the sponsor or investigator (NLM fact sheet). Investigators running trials in your condition know the evidence and how hard it is to study.
- Advisory committees. The FDA uses committees and panels to get independent expert advice on scientific, technical and policy matters, and publishes rosters and meeting materials for each, including the device panels (FDA advisory committees).
- Industry relationships. CMS's Open Payments program publishes a searchable database of payments that drug and device companies report making to covered recipients such as physicians. Its Program Year 2025 data covers 17.07 million records totaling $14.67 billion (CMS Open Payments). One category is consulting fees, which CMS describes as payments for advice and expertise about a medical product or treatment, usually under a written agreement (natures of payment). A physician who consults for several device companies is probably a recognized KOL, which you want to know before asking their opinion of a competitor's product. CMS does not comment on which relationships are beneficial or conflicts of interest.
Put the names in a short table with evidence of influence, fit with your question, known industry ties and group. Twenty names is plenty for a first pass.
Ask about specific cases
Broad questions get the answer a KOL gives from a conference stage. Ask about specific decisions instead:
- When did you last change how you manage these wounds, and what made you change?
- What would a device like this have to show before you used it on your patients? What should a study measure, and over what period?
- Which published results do colleagues still argue about?
- Who else in your hospital would need to agree before a new device is used?
- If you had this question, who would you call?
The last question often gives you the next three names. KOLs often champion particular approaches, so treat each answer as one informed view and check it against practitioners and data. What to do when experts disagree and how to check interviews against product and market data cover how.
Pay for time, and keep research away from sales
Paying clinicians is regulated, and the rules depend on who you are and how you pay. This is general information, not legal advice. If you are a drug or device manufacturer, involve compliance or counsel before the first payment.
- Keep research calls separate from speaking or promotional work. The HHS Office of Inspector General's 2020 Special Fraud Alert on speaker programs notes that drug and device companies reported paying nearly $2 billion to healthcare professionals for speaker-related services over three years. Its warning signs include paying above fair market value, pay that takes into account the business a clinician generates, and sales or marketing influence over who is chosen. The alert explains that the federal anti-kickback statute makes it a crime to knowingly and willfully pay anything of value to induce or reward referrals or orders of items paid for by federal health care programs.
- Set the fee in advance. Base it on fair market value for the time, and never tie it to whether the person uses, prescribes or recommends your product. Have medical or scientific staff choose whom to approach, not sales.
- Check whether a payment is reportable. The Insights Association explains in a 2014 position paper that the Sunshine Act excludes payments made through a third party when the manufacturer does not know who received them, which is how blinded market research usually works. If a manufacturer wants to pay a named physician directly, ask counsel first.
- Plan for safety reports. If you hold the license for a product the KOL discusses, you may have adverse event reporting duties; pharmaceutical market research explains the industry guidelines.
- Disclose paid relationships in marketing. If you later quote a paid KOL publicly, the FTC's Endorsement Guides require a connection such as payment, which might materially affect how much weight the audience gives an endorsement, to be disclosed clearly and conspicuously when the audience would not expect it. One FTC example is a physician paid to post about a product on social media (16 CFR 255.5).
Outside healthcare, look for whose work gets copied
The same method works in other markets. In B2B software, influential people may be practitioners who write and speak about their work, organizers of professional communities, or former operators who advise many companies. Look for who peers cite and whose templates others copy, then check that their experience matches your question. A KOL often shapes which vendors make a shortlist without signing anything, so also interview the people who actually buy.
Start with 20 names and one question
Write the one question you need a KOL to answer and the group whose opinion matters. Pull 20 names from PubMed and ClinicalTrials.gov, look each one up in Open Payments, and choose the five whose work fits best. Then add three practitioners who do the work every day.
People who rarely publish, such as wound-care nurses or hospital supply chain staff, won't show up in those records. The directory pages for hospital supply chain experts and medical device consultants list people by role instead. On Instant Expert you set what each person receives and our fee is added on top, so a $300 offer costs you $375, charged only if they book or answer. Set that amount by fair market value before anything goes out, for the reasons above. The buyer picks each person by name or role, so these are not blinded payments; a drug or device manufacturer should check its reporting duties with counsel first.
If you're the KOL being asked
Recognized experts get a steady stream of paid requests, so it helps to know what a yes commits you to. An Instant Expert invitation names the sender's topic and the amount you would receive, which is yours in full. You have 7 days to book a call of 15 to 60 minutes on a video link we provide, or to send a written or voice answer instead. Payment goes out 24 hours after the call, by direct deposit or gift card, or you can have the amount donated to a charity you pick, and we make the donation.
If your employer has a conflict of interest or outside activities policy, read it before you accept, and check how it treats a fee you have donated; policies differ on that. Every invitation also has a link to stop future requests, and it covers every address we hold for you.
If you appear on a directory page, its "This is me" button lets you claim the profile, see the rate buyers are shown for you and set your own. Buyers don't see that you changed it.